CIK 0001326205 · Non-accelerated filer<br>Smaller reporting company
IGC Pharma, Inc.
Sign in to watch- Ticker
- IGC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MD
- Entity type
- operating
- EIN
- 202760393
- Phone
- 301-529-4996
- Business address
- 10224 FALLS ROAD, POTOMAC, MD, 20854
- Former names
- India Globalization Capital, Inc.
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 1,850 shares at an average $4.85 ($8,980)
- 4 Open-market sale 10% owner sold 17,832 shares at an average $4.94 ($83,195)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 26,860 shares at an average $5.14 ($133,004)
- 4 Open-market buy 10% owner bought 25,685 shares at an average $5.43 ($138,355)
- 4 Open-market sale 10% owner sold 42,746 shares at an average $5.47 ($232,637)
- 4 Open-market buy 10% owner bought 34,005 shares at an average $5.21 ($177,026)
- 4 Open-market sale 10% owner sold 58,695 shares at an average $5.00 ($293,522)
- 4 Open-market sale 10% owner sold 24,699 shares at an average $4.69 ($115,797)
- 4 Open-market buy 10% owner bought 29,608 shares at an average $4.82 ($128,252)
- 4 Open-market buy 10% owner bought 14,465 shares at an average $4.38 ($63,310)
- 3 Insider Initial Statement of Ownership
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 8-K Event Other events
- 8-K Event Results of operations · Other events
- 10KSB Other 10KSB
- SC 13G Stake Amended Statement of Ownership
Page 34 of 41 · 818 filings